ElliotKeithChartashMD

PubMed

• 104 citations
  First-in-human phase 1 study of the anti–TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non–small cell lung cancer
  Jiaxin Niu, Corinne Maurice-Dror, Dongwhane Lee, Dai Woo Kim, Adnan Nagrial, Mark Voskoboynik, H.C. Chung, K.F. Mileham, Ulka N. Vaishampayan, Drew W. Rasco, Talia Gol...> ;Annals of Oncology. 2021 Nov 17
• 22 citations
  Phase I Study of MK-4166, an Anti-human Glucocorticoid-Induced TNF Receptor Antibody, Alone or with Pembrolizumab in Advanced Solid Tumors.
  Kyriakos P. Papadopoulos, Karen A. Autio, Talia Golan, Konstantin Dobrenkov, Elliot Chartash, Qiusheng Chen, Richard Wnek, Georgina V. Long> ;Clinical Cancer Research. 2021 Apr 1
• 1 citations
  Corrigendum to "A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" [Eur J Canc 131 (2020)...
  Mallika Lala, Tommy Ruosi Li, Dinesh P. de Alwis, Vikram Sinha, Kapil Mayawala, Mengyao Li, Noboru Yamamoto, Lillian L. Siu, Elliot Chartash, Hesham Aboshady, Lokesh Jain> ;European Journal of Cancer. 2021 Jan 4
• 34 citations
  First-in-human phase 1 study of MK-1248, an anti-glucocorticoid-induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizuma...
  Ravit Geva, Mark Voskoboynik, Konstantin Dobrenkov, Kapil Mayawala, Jennifer Gwo, Richard Wnek, Elliot Chartash, Georgina V. Long> ;Cancer. 2020 Nov 15
• 86 citations
  A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation.
  Mallika Lala, Tommy Ruosi Li, Dinesh P. de Alwis, Vikram Sinha, Kapil Mayawala, Noboru Yamamoto, Lillian L. Siu, Elliot Chartash, Hesham Aboshady, Lokesh Jain> ;European Journal of Cancer. 2020 Apr 15
• 865 citations
  PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
  Paul Nghiem, Shailender Bhatia, Evan J. Lipson, Ragini R. Kudchadkar, Natalie J. Miller, Lakshmanan Annamalai, Sneha Berry, Elliot Chartash, Adil Daud, Steven P. Fling...> ;The New England Journal of Medicine. 2016 Apr 19
• 59 citations
  Vaccine Responses in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol: Results from a Single-blind Randomized Phase IV Trial
  Alan Kivitz, Joy Schechtman, Michele Texter, Andreas Fichtner, Marc de Longueville, Elliot Chartash> ;The Journal of Rheumatology. 2014 Apr 1
• 160 citations
  Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis : Results of a Ran...
  Alexa B. Kimball, Kenneth B. Gordon, Richard G. Langley, Alan Menter, Elliot K. Chartash, Joaquin Mario Valdes> ;Archives of Dermatology. 2008 Feb 1
• 51 citations
  Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, i...
  Susan Yount, Mark V. Sorensen, David Cella, Nishan Sengupta, James Grober, Elliot K. Chartash> ;Clinical and Experimental Rheumatology. 2007 Nov 1
• 156 citations
  Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study.
  Michael E. Weinblatt, Edward C. Keystone, Daniel E. Furst, Arthur Kavanaugh, Elliot Chartash, Oscar G. Segurado> ;Annals of the Rheumatic Diseases. 2006 Jun 1
• 364 citations
  Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis.
  David Cella, Susan Yount, Mark V. Sorensen, Elliot K. Chartash, Nishan Sengupta, James Grober> ;The Journal of Rheumatology. 2005 May 1
• 937 citations
  Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoi...
  Edward C. Keystone, Arthur Kavanaugh, John T. Sharp, Hyman Tannenbaum, Ye Hua, Leah S. Teoh, Steven A. Fischkoff, Elliot Chartash> ;Arthritis and Rheumatism. 2004 May 1
• 400 citations
  Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthriti...
  Daniel E. Furst, Michael Schiff, Roy Fleischmann, Vibeke Strand, C. Birbara, Daniele Compagnone, Steven A. Fischkoff, Elliot Chartash> ;The Journal of Rheumatology. 2003 Dec 1
• 215 citations
  Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis...
  Michael H. Weisman, Larry W. Moreland, Daniel E. Furst, Michael E. Weinblatt, Edward C. Keystone, Harold E. Paulus, Leah S. Teoh, Raja B. Velagapudi, Peter Noertersheu...> ;Clinical Therapeutics. 2003 Jun 1
• 1364 citations
  Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: ...
  Michael E. Weinblatt, Edward C. Keystone, Daniel E. Furst, Larry W. Moreland, Michael H. Weisman, C. Birbara, Leah A. Teoh, Steven A. Fischkoff, Elliot Chartash> ;Arthritis and Rheumatism. 2003 Jan 1
• 38 citations
  Clonal expansion is a characteristic feature of the B-cell repertoire of patients with rheumatoid arthritis
  Kenji Itoh, Varsha Patki, Richard Furie, Elliot K. Chartash, Rita I. Jain, Lewis B. Lane, Stanley E. Asnis, Nicholas Chiorazzi> ;Arthritis Research. 1999 Dec 1
• 50 citations
  A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome.
  Naoto Hirose, Roxanne Williams, Alan R. Alberts, Richard A. Furie, Elliot Chartash, Rita I. Jain, Cristina Sison, Robert G. Lahita, Joan T. Merrill, Elena Cucurull, Az...> ;Arthritis and Rheumatism. 1999 Aug 1
• 8 citations
  Ig H and L Chain Variable Region Gene Sequence Analyses of Twelve Synovial Tissue-Derived B Cell Lines Producing IgA, IgG, and IgM Rheumatoid Factors Structure/Functio...
  Rita I. Jain, Franco Fais, Stuart Kaplan, Brian Sellars, Ruth Brooks, Elliot K. Chartash, Richard Furie, Shiori Hashimoto, Nicholas Chiorazzi> ;Autoimmunity. 1995 Jan 1
• 54 citations
  Systemic lupus erythematosus complicated by thrombotic microangiopathy
  Rita I. Jain, Elliot K. Chartash, Myron Susin, Richard Furie> ;Seminars in Arthritis and Rheumatism. 1994 Dec 1
• 28 citations
  Reversible monocular blindness complicating Churg-Strauss syndrome.
  Alberts Ar, Lasonde R, Ackerman Kr, Elliot Chartash, Susin M, Richard Furie> ;The Journal of Rheumatology. 1994 Feb 1
• 77 citations
  Cardiac manifestations of the antiphospholipid syndrome
  Stuart Kaplan, Elliot K. Chartash, Roy A. Pizzarello, Richard A. Furie> ;American Heart Journal. 1992 Nov 1
• 12 citations
  Septic subdeltoid bursitis
  Elliot K. Chartash, Philip K. Good, Elaine S. Gould, Richard Furie> ;Seminars in Arthritis and Rheumatism. 1992 Aug 1
• 3 citations
  Biochemical basis of synergy between antigen and T-helper (Th) cell-mediated activation of resting human B cells.
  Elliot K. Chartash, Mary K. Crow, Steven M. Friedman> ;The Journal of Clinical Investigation. 1989 Nov 1
• 16 citations
  T helper cell-induced CD23 (BLAST-2) expression: an activation marker for the high density fraction of human B cells.
  Juan Angel Jover, Elliot K. Chartash, Barbara Kushner, Steven M. Friedman, Mary K. Crow> ;Clinical Immunology and Immunopathology. 1989 Oct 1
• 28 citations
  Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion.
  Jeffrey Laurence, Steven M. Friedman, Elliot K. Chartash, Mary K. Crow, David N. Posnett> ;The Journal of Clinical Investigation. 1989 Jun 1
• Join now to see all